Table 2 Short and long-term outcomes of MIOCA and MINOCA ACS patients, according to admission hyperglycemia

Short-term outcomes

 In-hospital death, n (%)

10 (0.8)

40 (4.6)

< 0.001

1 (0.5)

1 (2.6)

ns

ns

  With T2DM

0 (0)

20 (4.4)

0.020

–

–

–

 Intra-hospital arrhythmias, n (%)

59 (4.5)

84 (9.7)

< 0.001

5 (2.6)

5 (13.5)

0.003

ns

  Atrial fibrillation, n (%)

39 (3)

52 (6)

2 (1)

3 (7.9)

  Ventricular arrhythmias, n (%)

20 (1.5)

32 (3.6)

3 (1.5)

2 (5.7)

 IABP, n (%)

12 (0.9)

34 (3.9)

< 0.001

–

–

–

Hospital length of stay days, median [IQR]

5 [4–7]

6 [4–10]

< 0.001

5 [4–6]

5 [4–8]

ns

ns

Long-term outcomes*

 All-cause death, n (%)

117 (8.9)

143 (17.2)

< 0.001

15 (7.7)

8 (22.9)

0.006

ns

  With T2DM

20 (16.9)

80 (18.4)

0.718

2 (15.4)

4 (26.7)

0.468

 Cardiovascular-death, n (%)

67 (5.1)

84 (10.1)

< 0.001

7 (3.6)

5 (14.3)

0.009

ns

  With T2DM

11 (9.3)

51 (11.7)

0.46

1 (7.7)

3 (20.0)

0.35

 Re-AMI, n (%)

58 (4.4)

41 (4.7)

ns

1 (0.5)

0 (0)

ns

ns

 Stroke, n (%)

2 (0.2)

1 (0.1)

ns

0 (0)

0 (0)

ns

ns

 Heart failure, n (%)

108 (10.3)

103 (15.8)

0.001

8 (5.2)

4 (15.4)

ns

ns

 MACE, n (%)

212 (16)

251 (28.6)

< 0.001

20 (10.3)

7 (18.4)

ns

ns

 MAE, n (%)

260 (19.7)

304 (34.7)

< 0.001

27 (13.8)

10 (26.3)

ns

ns